Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Smoking Cessation 2Neoplasms 2Lung Neoplasms 2Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Neoplasm Metastasis 1Motor Activity 1Lymphoma 1Leukemia 1Inflammation 1Colorectal Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

semaglutide 1cytisine 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Topiramate 1Tirzepatide 1Surgical Procedures, Operative 1Spirometry 1Radiotherapy 1Qsymia 1Phentermine 1Naltrexone 1Mindfulness 1Liraglutide 1Hematologic Tests 1Glucagon-Like Peptide-1 Receptor 1Diethylpropion 1Diet Therapy 1Bupropion 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Inflammation × Hematologic Tests × Clear all
NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡